Advertisement
Advertisement
PBH
Prestige Consumer Healthcare Inc.
66.45
USDSponsored
+0.90
+1.38%
Feb 06, 15:59 UTC -5
Closed
After-Market
66.36
-0.09
-0.14%
PBH Earnings Reports
Positive Surprise Ratio
PBH beat 31 of 40 last estimates.
78%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q4 26 (Revenue/ EPS)
$306.36M
/$1.42
Implied change from Q3 26 (Revenue/ EPS)
+8.09%
/+25.66%
Implied change from Q4 25 (Revenue/ EPS)
+3.32%
/+7.58%
Prestige Consumer Healthcare Inc. earnings per share and revenue
On Feb 05, 2026, PBH reported earnings of 1.13 USD per share (EPS) for Q3 26, missing the estimate of 1.15 USD, resulting in a -1.36% surprise. Revenue reached 283.44 million, compared to an expected 284.83 million, with a -0.49% difference. The market reacted with a -2.21% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 8 analysts forecast an EPS of 1.42 USD, with revenue projected to reach 306.36 million USD, implying an increase of 25.66% EPS, and increase of 8.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
FAQ
What were Prestige Consumer Healthcare Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Prestige Consumer Healthcare Inc. reported EPS of $1.13, missing estimates by -1.36%, and revenue of $283.44M, -0.49% below expectations.
How did the market react to Prestige Consumer Healthcare Inc.'s Q3 2026 earnings?
The stock price moved down -2.21%, changed from $67.03 before the earnings release to $65.55 the day after.
When is Prestige Consumer Healthcare Inc. expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Prestige Consumer Healthcare Inc.'s next earnings report?
Based on 8
analysts, Prestige Consumer Healthcare Inc. is expected to report EPS of $1.42 and revenue of $306.36M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement